Canada's GNA challenge from Quebec could pave way for genetic discrimination

NewsGuard 100/100 Score

If Canada's Genetic Non-Discrimination Act (GNA) is overturned by a challenge from the Province of Quebec, it will open the doors to genetic discrimination, argue authors in a commentary in CMAJ (Canadian Medical Association Journal).

"The GNA is a critical law affording comprehensive protection prohibiting genetic discrimination by any individual or sector," writes Dr. Yvonne Bombard, scientist at the Li Ka Shing Knowledge Institute of St. Michael's Hospital, with Bev Heim-Myers, chair of the Canadian Coalition for Genetic Fairness and CEO of the Huntington Society of Canada.

The act protects genetic test information from being required in a contract negotiation or by any person or service provider such as an insurer, employer, school or adoption agency. It became law in Canada in May 2017.

Although advances in genomics are helping prevent, treat and diagnose diseases, people may decline useful genomic testing as they are afraid that personal genomic information could be used to deny them insurance coverage by third parties or compromise employment opportunities. This fear can also prevent patients from participating in medical research.

"Such fear creates barriers to accessing important information that can end costly, burdensome diagnostic odysseys, guide medical management and improve a patient's quality of life," write Bombard and Heim-Myers.

The GNA makes it a criminal offense to require a person to take, or reveal results of, a genetic test. However, health care professionals are exempt if they are treating that person.

Quebec has challenged the law, arguing it is not constitutional.

"For now, the genetic test information of all people living in Canada, no matter where they live, is protected by law," state the authors. "And it is important that the GNA remains intact."

Source: http://www.cmaj.ca/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Molecular pathology of Schaaf-Yang syndrome: Insights into MAGEL2 gene mutations and truncated proteins